| 臺大學術典藏 |
2022-03-08T03:44:02Z |
S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma
|
Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
Metabolic alterations in pancreatic cancer detected by in vivo1h-mr spectroscopy: Correlation with normal pancreas, pet metabolic activity, clinical stages, and survival outcome
|
Chang C.-K.; Shih T.T.-F.; Tien Y.-W.; Chang M.-C.; Chang Y.-T.; SHIH-HUNG YANG; Cheng M.-F.; Chen B.-B. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v
|
Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; SHIH-HUNG YANG; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; Wang H.-P.; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; Hsieh M.-S.; SHIH-HUNG YANG; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-03-08T03:43:58Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T23:55:19Z |
Long-term outcomes of moyamoya disease following indirect revascularization in middle adulthood: A prospective, quantitative study
|
Chou, Sheng Che; YA-FANG CHEN; CHUNG-WEI LEE; SHIH-HUNG YANG; MENG-FAI KUO |
| 臺大學術典藏 |
2022-02-14T23:55:15Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen, Yi Lun; CHIAO-LING TSAI; Chia-Hsien Cheng; Chun-wei Wang; Shih-Hung Yang; Yu-Wen Tien; Sung-Hsin Kuo |
| 臺大學術典藏 |
2021-12-21T23:17:36Z |
A Dynamic Interbody Cage Improves Bone Formation in Anterior Cervical Surgery: A Porcine Biomechanical Study
|
SHIH-HUNG YANG; FU-REN XIAO; Lai, Dar Ming; Wei, Chung Kai; FON-YIH TSUANG |
| 臺大學術典藏 |
2021-12-21T23:17:36Z |
Surgical application of endoscopic-assisted minimally-invasive neurosurgery to traumatic brain injury: Case series and review of literature
|
Tseng, Wei Lung; LU-TING KUO; Chen, Chien Min; SHIH-HUNG YANG; Tang, Chi Tun; Lai, Dar Ming; ABEL PO-HAO HUANG |
| 臺大學術典藏 |
2021-10-21T23:27:09Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu, Li Chun; HSIANG-FONG KAO; BANG-BIN CHEN; TING-CHUN KUO; SUNG-HSIN KUO; YU-WEN TIEN; Bai, Li Yuan; ANN-LII CHENG; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-09-14T23:18:31Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
|
SUNG-HSIN KUO; SHIH-HUNG YANG; Wei, Ming Feng; Lee, Hsiao Wei; YU-WEN TIEN; ANN-LII CHENG; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-09-14T23:18:31Z |
Metabolic alterations in pancreatic cancer detected by in vivo1h-mr spectroscopy: Correlation with normal pancreas, pet metabolic activity, clinical stages, and survival outcome
|
Chang, Chih Kai; TIFFANY TING-FANG SHIH; YU-WEN TIEN; MING-CHU CHANG; YU-TING CHANG; SHIH-HUNG YANG; MEI-FANG CHENG; BANG-BIN CHEN |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]
|
SHIH-HUNG YANG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:06Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:06Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H. |
